The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues
Abstract
Peroxisome proliferator-activated receptor γ (PPARγ) agonists, including the glitazone class of drugs, are insulin sensitizers that reduce glucose and lipid levels in patients with type 2 diabetes mellitus. To more fully understand the molecular mechanisms underlying their therapeutic actions, we have characterized the effects of the potent, tyrosine-based PPARγ ligand GW1929 on serum glucose and lipid parameters and gene expression in Zucker diabetic fatty rats. In time-course studies, GW1929 treatment decreased circulating FFA levels before reducing glucose and triglyceride levels. We used a comprehensive and unbiased messenger RNA profiling technique to identify genes regulated either directly or indirectly by PPARγ in epididymal white adipose tissue, interscapular brown adipose tissue, liver, and soleus skeletal muscle. PPARγ activation stimulated the expression of a large number of genes involved in lipogenesis and fatty acid metabolism in both white adipose tissue and brown adipose tissue. In muscle, PPARγ agonist treatment decreased the expression of pyruvate dehydrogenase kinase 4, which represses oxidative glucose metabolism, and also decreased the expression of genes involved in fatty acid transport and oxidation. These changes suggest a molecular basis for PPARγ-mediated increases in glucose utilization in muscle. In liver, PPARγ activation coordinately decreased the expression of genes involved in gluconeogenesis. We conclude from these studies that the antidiabetic actions of PPARγ agonists are probably the consequence of 1) their effects on FFA levels, and 2), their coordinate effects on gene expression in multiple insulin-sensitive tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
A novel method for real time quantitative RT-PCR.
Gibson, U. E., Heid, C. A., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.995 · Cited by 2,075
Transcriptional regulation of adipogenesis
Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. (2000) · Genes & Development · doi:10.1101/gad.14.11.1293 · Cited by 1,898
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 3×
“PPARg activation either stimulates (1) or represses (2) key metabolic pathways in adipose, muscle, and liver and promotes a flux of FFA from muscle and liver to adipose.”
BackgroundSelf-citationPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes
Saltiel, A. R., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1661 · Cited by 1,053
Soria, B., Roche, E., Berná, G., León-Quinto, T., Reig, J. A., & Martín, F. (2000) · Diabetes · doi:10.2337/diabetes.49.2.157 · Cited by 862
Hu, E., Tontonoz, P., & Spiegelman, B. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9856 · Cited by 656
PPARγ, the ultimate thrifty gene
Auwerx, J. (1999) · Diabetologia · doi:10.1007/s001250051268 · Cited by 612
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean
Clapham, J. C., Arch, J. R. S., Chapman, H., Haynes, A., Lister, C., Moore, G. B. T., Piercy, V., Carter, S. A., Lehner, I., Smith, S. A., et al. (2000) · Nature · doi:10.1038/35019082 · Cited by 604
PPARγ2 Regulates Adipose Expression of the Phosphoenolpyruvate Carboxykinase Gene
Tontonoz, P., Hu, E., Devine, J., Beale, E. G., & Spiegelman, B. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.351 · Cited by 559
Martin, G., Schoonjans, K., Lefebvre, A.-M., Staels, B., & Auwerx, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28210 · Cited by 551 · cited 1×
“PEPCK and acyl-CoA synthetase were previously shown to be regulated by glitazones and PPARg (14, 15).”
BackgroundOrphan Nuclear Receptors: Shifting Endocrinology into Reverse
Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1999) · Science · doi:10.1126/science.284.5415.757 · Cited by 499
Self-citationFujiwara, T., Yoshioka, S., Yoshioka, T., Ushiyama, I., & Horikoshi, H. (1988) · Diabetes · doi:10.2337/diab.37.11.1549 · Cited by 473
Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Suter, S. L., Nolan, J. J., Wallace, P., Gumbiner, B., & Olefsky, J. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.193 · Cited by 420
Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism.
Boss, O., Hagen, T., & Lowell, B. B. (2000) · Diabetes · doi:10.2337/diabetes.49.2.143 · Cited by 414
Hofmann, C. (1994) · Endocrinology · doi:10.1210/en.134.1.264 · Cited by 387
An Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγ
Lowell, B. B. (1999) · Cell · doi:10.1016/s0092-8674(00)81654-2 · Cited by 383
De Vos, P., Lefebvre, A. M., Miller, S. G., Guerre-Millo, M., Wong, K., Saladin, R., Hamann, L. G., Staels, B., Briggs, M. R., & Auwerx, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118860 · Cited by 357
Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen, C. B., & Lazar, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5793 · Cited by 337
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9804127 · Cited by 301
Self-citationWu, P., Inskeep, K., Bowker-Kinley, M. M., Popov, K. M., & Harris, R. A. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1593 · Cited by 290
Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin
Rebrin, K., Steil, G. M., Getty, L., & Bergman, R. N. (1995) · Diabetes · doi:10.2337/diab.44.9.1038 · Cited by 270
Heuckeroth, R. O., Birkenmeier, E. H., Levin, M. S., & Gordon, J. I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47992-6 · Cited by 227
Loviscach, M., Rehman, N., Carter, L., Mudaliar, S., Mohadeen, P., Ciaraldi, T. P., Veerkamp, J. H., & Henry, R. R. (2000) · Diabetologia · doi:10.1007/s001250050048 · Cited by 176
Brown, K. K., Henke, B. R., Blanchard, S. G., Cobb, J. E., Mook, R., Kaldor, I., Kliewer, S. A., Lehmann, J. M., Lenhard, J. M., Harrington, W. W., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1415 · Cited by 172
Self-citationGene expression analysis by transcript profiling coupled to a gene database query
Shimkets, R. A., Lowe, D. G., Tai, J. T.-N., Sehl, P., Jin, H., Yang, R., Predki, P. F., Rothberg, B. E. G., Murtha, M. T., Roth, M. E., et al. (1999) · Nature Biotechnology · doi:10.1038/11743 · Cited by 168
Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPAR Agonist) Action
Zierath, J. R., Ryder, J. W., Doebber, T. W., Woods, J. W., Wu, M. S., Ventre, J. R., Li, Z., McCrary, C. T., Berger, J. P., Zhang, B., et al. (1998) · Endocrinology · doi:10.1210/endo.139.12.6364 · Cited by 136
Majer, M., Popov, K. M., Harris, R. A., Bogardus, C., & Procházka, M. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2748 · Cited by 112
Park, K. S., Ciaraldi, T. P., Lindgren, K., Abrams-Carter, L., Mudaliar, S. R. D., Nikoulina, S. E., Tufari, S. R., Veerkamp, J. H., Vidal‐Puig, A., & Henry, R. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5034 · Cited by 103
Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and mice
Fujiwara, T., Okuno, A., Yoshioka, S., & Horikoshi, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90056-x · Cited by 100
Diamond, R. H., Du, K., Lee, V. M., Mohn, K. L., Haber, B. A., Tewari, D. S., & Taub, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82454-1 · Cited by 88
Thiazolidinediones for type 2 diabetes
Krentz, A. J. (2000) · BMJ · doi:10.1136/bmj.321.7256.252 · Cited by 83
Park, K. S., Ciaraldi, T. P., Abrams-Carter, L., Mudaliar, S. R. D., Nikoulina, S. E., & Henry, R. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4764 · Cited by 72
Matsuda, J., Hosoda, K., Itoh, H., Son, C., Doi, K., Hanaoka, I., Inoue, G., Nishimura, H., Yoshimasa, Y., Yamori, Y., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1809 · Cited by 63
Effects of troglitazone on substrate storage and utilization in insulin-resistant rats
Sreenan, S., Keck, S., Fuller, T., Cockburn, B. N., & Burant, C. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.6.e1119 · Cited by 51
Ide, T., NAKAZAWA, T., Mochizuki, T., & Murakami, K. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80019-0 · Cited by 42
Davies, G. F., Khandelwal, R. L., & Roesler, W. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00080-4 · Cited by 41
ADD-1 provides major new insight into the mechanism of insulin action
Flier, J. S., & Hollenberg, A. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14191 · Cited by 38
Shimokawa, T., Kato, M., Watanabe, Y., Hirayama, R., Kurosaki, E., Shikama, H., & Hashimoto, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9479 · Cited by 38
Haber, B. A., Naji, L., Chessman, D., & Taub, R. A. (1995) · Hepatology · doi:10.1002/hep.1840220331 · Cited by 35
Insulin sensitization in diabetic rat liver by an antihyperglycemic agent
Hofmann, C. A., Lorenz, K., Williams, D., Palazuk, B. J., & Colca, J. R. (1995) · Metabolism · doi:10.1016/0026-0495(95)90171-x · Cited by 25
Randle (1998) · doi:10.1002/(sici)1099-0895(199812)14:4<263::aid-dmr233>3.0.co;2-c
Cited by
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
(1998) · PubMed · Cited by 2,737
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Metadata
- Authors
- Way, J. M., Harrington, W. W., Brown, K. K., Gottschalk, W. K., Sundseth, S. S., Mansfield, T. A., Ramachandran, R. K., Willson, T. M., & Kliewer, S. A.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2001-03-01
- Volume
- 142
- Issue
- 3
- Pages
- 1269-1277
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2015495335
- Cited by
- 338
- References
- 48
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.